Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's disease

BACKGROUND AND PURPOSE: To assess the long-term safety and efficacy of pramipexole as a once-daily (q.d.) extended-release oral formulation in early or advanced Parkinson's disease (PD). METHODS: In two double-blind (DB) studies of early PD and one of advanced PD, active-treatment arms received...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Eur J Neurol
Hoofdauteurs: Hauser, R A, Schapira, A H V, Barone, P, Mizuno, Y, Rascol, O, Busse, M, Debieuvre, C, Fraessdorf, M, Poewe, W, Pramipexole ER Studies Group
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BlackWell Publishing Ltd 2014
Onderwerpen:
Original Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4282380/
https://ncbi.nlm.nih.gov/pubmed/24834511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ene.12375
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items